1
|
Zakaria M, Allard J, Ramirez-GarciaLuna JL, Matta J, Honjol Y, Schupbach D, Grant M, Mwale F, Harvey E, Merle G. Enhancing Bone Healing through Localized Cold Therapy in a Murine Femoral Fracture Model. Tissue Eng Part A 2024. [PMID: 39041619 DOI: 10.1089/ten.tea.2024.0069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/24/2024] Open
Abstract
Fracture healing, a critical and complex biological process, often presents challenges in clinical practice with the current standards failing to fully address the medical needs for rapid and effective recovery. In this work, a localized cold therapy is investigated as an alternative approach to expedite bone healing. We hypothesized that optimized cold application can enhance bone healing within a fracture model by inducing hypoxia, leading to accelerated angiogenesis along with improved osteogenesis. A short, localized cold exposure is directly applied to the fracture site over a four-week period in a mouse fracture model, aiming to assess its impact on bone formation through mechanisms of angiogenesis and osteogenesis. Our results revealed a significantly greater volume of new bone tissue and enhanced vascularity at the fracture site in the cold-treated group compared to controls. Calcified tissue histology analysis showed that the accelerated callus maturation and development of the vascular network following cold exposure were associated with an activity increase of alkaline phosphatase (ALP) and transient receptor potential vanilloid 1 (TRPV1). These biological changes were accompanied by a hypoxic environment induced during cold therapy. The study provides compelling evidence supporting the efficacy of intermittent cold therapy in accelerating fracture healing. These promising results highlight the need for further research in larger-scale studies and diverse fracture models, underlining the potential of cold therapy as a novel, non-invasive treatment strategy in orthopedic care.
Collapse
Affiliation(s)
- Matthew Zakaria
- McGill University, 845 Rue Sherbrooke O, Montreal, Canada, H3A 0G4;
| | - Jerome Allard
- Montreal Polytechnic, Chemical Engineering , Montreal, Quebec, Canada;
| | - Jose Luis Ramirez-GarciaLuna
- McGill University Faculty of Medicine, Surgery, 1650 Cedar Av., Room C10-124, Montreal, Quebec, Canada, H3G 1A4;
| | - Justin Matta
- McGill University Faculty of Medicine, Surgery, Montreal, Quebec, Canada;
| | - Yazan Honjol
- McGill University Faculty of Medicine, Surgery, Montreal, Quebec, Canada;
| | - Drew Schupbach
- McGill University Faculty of Medicine, Surgery, Montreal, Quebec, Canada;
| | - Michael Grant
- Lady Davis Institute for Medical Research, Montreal, Quebec, Canada;
| | - Fackson Mwale
- McGill University Faculty of Medicine, Surgery, Montreal, Quebec, Canada
- Lady Davis Institute for Medical Research, Montreal, Quebec, Canada;
| | - Edward Harvey
- McGill University Health Centre, Orthopaedic Surgery, Montreal, Quebec, Canada;
| | - Géraldine Merle
- Montreal Polytechnic, Chemical Engineering , Montreal, Quebec, Canada
- McGill University Faculty of Medicine, Surgery, Montreal, Quebec, Canada;
| |
Collapse
|
2
|
Stogov MV, Dyuryagina OV, Silant'eva TA, Shipitsyna IV, Kireeva EA, Stepanov MA. Evaluation of Biocompatibility of New Osteoplastic Xenomaterials Containing Zoledronic Acid and Strontium Ranelate. TRAUMATOLOGY AND ORTHOPEDICS OF RUSSIA 2023; 30:57-73. [DOI: 10.17816/2311-2905-2035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/03/2023]
Abstract
Background. The problem of improving the functional characteristics of implanted devices and materials used in traumatology and orthopedics is a topical issue.
Aim of the study to study biocompatibility of bovine bone matrix xenomaterials modified by zoledronic acid and strontium ranelate when implanted into the bone defect cavity.
Methods. The study was performed on 24 male rabbits of the Soviet Chinchilla breed. Test blocks of bone matrix were implanted into the cavity of bone defects of the femur. Group 1 animals (n = 8, control group) were implanted with bone xenogenic material (Bio-Ost osteoplastic matrix). Group 2 animals (n = 8) were implanted with bone xenogenic material impregnated with zoledronic acid. Group 3 animals (n = 8) were implanted with bone xenogeneic material impregnated with strontium ranelate. Supercritical fluid extraction technology was used to purify the material and impregnate it with zoledronic acid and strontium ranelate. Radiological, pathomorphological, histological and laboratory (hematology and blood biochemistry) diagnostic methods were used to assess biocompatibility. Follow-up period was 182 days after implantation.
Results. It was found out that on the 182nd day after implantation the median area of the newly-formed bone tissue in the defect modeling area in Group 1 was 79%, in Group 2 0%, in Group 3 67%. In Group 2 the maximum area by this period was filled with connective tissue 77%. Median relative area of implanted material fragments in Group 1 was 4%, in Group 2 23%, in Group 3 15%. No infection or material rejection was observed in animals of all groups. There were no signs of intoxication or prolonged systemic inflammatory reaction. Laboratory parameters did not change significantly over time. One animal in each group experienced one-time increase in C-reactive protein level against the background of leukocytosis. Two animals in Group 1 had a slight migration of implanted material under the skin, one animal developed arthritis of the knee joint.
Conclusion. Osteoplastic materials based on bovine bone xenomatrix and filled with zoledronic acid and strontium ranelate have acceptable values of biocompatibility including their safety profile.
Collapse
|
3
|
Vezenkova A, Locs J. Sudoku of porous, injectable calcium phosphate cements – Path to osteoinductivity. Bioact Mater 2022; 17:109-124. [PMID: 35386461 PMCID: PMC8964990 DOI: 10.1016/j.bioactmat.2022.01.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 12/28/2021] [Accepted: 01/03/2022] [Indexed: 12/16/2022] Open
Abstract
With the increase of global population, people's life expectancy is growing as well. Humans tend to live more active lifestyles and, therefore, trauma generated large defects become more common. Instances of tumour resection or pathological conditions and complex orthopaedic issues occur more frequently increasing necessity for bone substitutes. Composition of calcium phosphate cements (CPCs) is comparable to the chemical structure of bone minerals. Their ability to self-set and resorb in vivo secures a variety of potential applications in bone regeneration. Despite the years-long research and several products already reaching the market, finding the right properties for calcium phosphate cement to be osteoinductive and both injectable and suitable for clinical use is still a sudoku. This article is focused on injectable, porous CPCs, reviewing the latest developments on the path toward finding osteoinductive material, which is suitable for injection. Phase separation is an essential factor to be improved to obtain injectable material; several methods have been proposed. Osteoinductive bone substitutes – possible solution for bad mechanical performance of CPCs. Osteoinductivity of CPC could be attained even without the addition of different supplements. Less complex composition of CPC – potentially reduced price of the final product and wider availability on the market.
Collapse
|